Skip to main content

Advertisement

Log in

Exogenous reinfection of tuberculosis in a low-burden area

  • Original Paper
  • Published:
Infection Aims and scope Submit manuscript

Abstract

Purpose

Recurrence of tuberculosis (TB) can be the consequence of relapse or exogenous reinfection. The study aimed to assess the factors associated with exogenous TB reinfection.

Methods

Prospective cohort study based on the TB database, maintained at the Division of Infectious Diseases, Luigi Sacco Hospital (Milan, Italy). Time period: 1995–2010. Inclusion criteria: (1) ≥2 episodes of culture-confirmed TB; (2) cure of the first episode of TB; (3) availability of one Mycobacterium tuberculosis isolate for each episode. Genotyping of the M. tuberculosis strains to differentiate relapse and exogenous reinfection. Logistic regression analysis was used to assess the influence of risk factors on exogenous reinfections.

Result

Of the 4682 patients with TB, 83 were included. Of these, exogenous reinfection was diagnosed in 19 (23 %). It was independently associated with absence of multidrug resistance at the first episode [0, 10 (0.01–0.95), p = 0.045] and with prolonged interval between the first TB episode and its recurrence [7.38 (1.92–28.32) p = 0.004]. However, TB relapses occurred until 4 years after the first episode. The risk associated with being foreign born, extrapulmonary site of TB, and HIV infection was not statistically significant. In the relapse and re-infection cohort, one-third of the patients showed a worsened drug resistance profile during the recurrent TB episode.

Conclusions

Exogenous TB reinfections have been documented in low endemic areas, such as Italy. A causal association with HIV infection could not be confirmed. Relapses and exogenous reinfections shared an augmented risk of multidrug resistance development, frequently requiring the use of second-line anti-TB regimens.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Jasmer RM, Bozeman L, Schwartzman K, Cave MD, Saukkonen JJ, Metchock B, et al. Recurrent Tuberculosis in the United States and Canada. Am J Respir Crit Care Med. 2004;170:1360–6.

    Article  PubMed  Google Scholar 

  2. Picon PD, Bassanesi SL, Avancini Caramori ML, Targa Ferreira RL, Jarczewski CA, Rodrigues de Borba Vieira P. Risk factors for recurrence of tuberculosis. J Bra Pneumol 2007; 33:572–578.

  3. Charalambous S, Grant AD, Moloi V, Warren R, Day JH, van Helden P, et al. Contribution of reinfection to recurrent tuberculosis in South African gold miners. Int J Tuberc Lung Dis. 2008;12:942–8.

    CAS  PubMed  Google Scholar 

  4. Bang D, Andersen AB, Thomsen VO, Lillebaek T. Recurrent tuberculosis in Denmark: relapse vs re-infection. Int J Tuberc Lung Dis. 2010;14:447–53.

    CAS  PubMed  Google Scholar 

  5. Luzze H, Johnson DF, Dickman K, Mayanja-Kizza H, Okwera A, Eisenach K, et al. Relapse more common than reinfection in recurrent tuberculosis 1-2 years post treatment in urban Uganda. Int J Tuberc Lung Dis. 2013;17:361–7.

    Article  CAS  PubMed  Google Scholar 

  6. Das S, Chan SL, Allen BW, Mitchison DA, Lowrie DB. Application of DNA fingerprinting with IS986 to sequential mycobacterial isolates obtained from pulmonary tuberculosis patients in Hong Kong before, during and after short-course chemotherapy. Tuberc Lung Dis. 1993;74:4751.

    Article  Google Scholar 

  7. Mallory KF, Churchyard GJ, Kleinschmidt I, De Cock KM, Corbett EL. The impact of HIV infection on recurrence of tuberculosis in South African gold miners. Int J Tuberc Lung Dis. 2000;4:455–62.

    CAS  PubMed  Google Scholar 

  8. Das S, Paramasivan CN, Lowrie DB, Prabhakar R, Narayanan PR. IS6110 restriction fragment length polymorphism typing of clinical isolates of Mycobacterium tuberculosis from patients with pulmonary tuberculosis in Madras, south India. Tuber Lung Dis. 1995;76:550–4.

    Article  CAS  PubMed  Google Scholar 

  9. van Rie A, Warren R, Richardson M, Victor TC, Gie RP, Enarson DA, et al. Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. N Engl J Med. 1999;341:1174–9.

    Article  PubMed  Google Scholar 

  10. Crampin AC, Mwaungulu JN, Mwaungulu FD, Mwafulirwa DT, Munthali K, Floyd S, et al. Recurrent TB: relapse or reinfection? The effect of HIV in a general population cohort in Malawi. AIDS. 2010;24:417–26.

    Article  PubMed Central  PubMed  Google Scholar 

  11. Sonnenberg P, Murray J, Glynn JR, Shearer S, Kambashi B, Godfrey-Faussett P. HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers. Lancet. 2001;358:1687–93.

    Article  CAS  PubMed  Google Scholar 

  12. Bandera A, Gori A, Catozzi L, Degli Esposti A, Marchetti G, Molteni C, et al. Molecular epidemiology study of exogenous reinfection in an area with a low incidence of tuberculosis. J Clin Microbiol. 2001;39:2213–8.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  13. Garcia de Viedma DG, Marin M, Hernangomez S, Diaz M, Serrano MJ, Alcala L, et al. Tuberculosis recurrences: reinfection plays a role in a population whose clinical/epidemiological characteristics do not favor reinfection. Arch Intern Med. 2002;162:1873–9.

    Article  PubMed  Google Scholar 

  14. Fitzpatrick LK, Okwera A, Mugerwa R, Ridzon R, Ehiner J, Onorato I. An investigation of suspected exogenous reinfection in tuberculosis patients in Kampala, Uganda. Int J Tuberc Lung Dis. 2002;6:550–2.

    CAS  PubMed  Google Scholar 

  15. Lambert ML, Hasker E, Van Duen A, Roberfroid D, Boelaert M, Van der Stuyft P. Recurrence in tuberculosis: relapse or reinfection. Lancet Infect Dis. 2003;3:282–7.

    Article  PubMed  Google Scholar 

  16. Chiang CY, Riley LW. Exogenous reinfection in tuberculosis. Lancet Infect Dis. 2005;5:629–36.

    Article  PubMed  Google Scholar 

  17. Wang JY, Lee LN, Lai HC, Hsu HL, Liaw YS, Hsueh PR, et al. Prediction of the tuberculosis reinfection proportion from the local incidence. J Infect Dis. 2007;196:281–8.

    Article  PubMed  Google Scholar 

  18. Franzetti F, Gori A, Iemoli E, Meraviglia P, Mainini F, Quirino T, et al. Outcome of multidrug-resistant tuberculosis in human immunodeficiency virus-infected patients. Clin Infect Dis. 1999;29:553–60.

    Article  CAS  PubMed  Google Scholar 

  19. Moro ML, Gori A, Errante I, Infuso A, Franzetti F, Sodano L, et al. An outbreak of multidrug-resistant tuberculosis involving HIV-infected patients of two hospitals in Milan, Italy. AIDS. 1998;12:1095–102.

    Article  CAS  PubMed  Google Scholar 

  20. Codecasa LR, Porretta AD, Gori A, Franzetti F, Degli Esposti A, Lizioli A, et al. Tuberculosis among immigrants from developing countries in the province of Milan, 1993–1996. Int J Tuberc Lung Dis. 1999;3:589–95.

    CAS  PubMed  Google Scholar 

  21. CCM, ISS e Regione Emilia-Romagna. La tubercolosi in Italia. Rapporto 2008. http://www.salute.gov.it/imgs/c_17_pubblicazioni_1472_allegato.pdf.

  22. Istituto Superiore di Sanità. Notiziario ISS. 2014;27(9):16–22.

    Google Scholar 

  23. Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, Kuijper S, et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol. 1997;35:907–14.

    PubMed Central  CAS  PubMed  Google Scholar 

  24. Supply P, Lesjean S, Savine E, Kremer K, Van Soolingen D, Locht C. Automated high-throughput genotyping for study of global epidemiology of Mycobacterium tuberculosis based on mycobacterial interspersed repetitive units. J Clin Microbiol. 2001;39:3536–71.

    Article  Google Scholar 

  25. World Health Organization; International union Against Tuberculosis and Lung Disease and Royal Netherlands Tuberculosis Association. Revised international definitions in tuberculosis control. Int J Tuberc Lung Dis. 2001;5:213–5.

    Google Scholar 

  26. Fine PEM, Small PM. Exogenous reinfection in tuberculosis. N Engl J Med. 1999;341:1226–7.

    Article  CAS  PubMed  Google Scholar 

  27. Sudre P, Pfyffer GE, Bodmer T, Prod’hom G, Furrer H, Bassetti S, et al. Molecular epidemiology of tuberculosis among HIV-infected persons in Switzerland: a countrywide 9-year cohort study: swiss HIV Cohort Study. Infection. 1999;27:323–30.

    Article  CAS  PubMed  Google Scholar 

  28. El Sahly HM, Wright JA, Soini H, Bui TT, Williams-Bouyer N, Escalante P, et al. Recurrent tuberculosis in Houston, Texas: a population-based study. Int J Tuberc Lung Dis. 2004;8:333–40.

    PubMed  Google Scholar 

  29. Sahadevan R, Narayanan S, Paramasivan CN, Prabhakar R, Narayanan PR. Restriction fragment length polymorphism typing of clinical isolates of Mycobacterium tuberculosis from patients with pulmonary tuberculosis in Madras, India, by use of direct-repeat probe. J Clin Microbiol. 1995;33:3037–9.

    PubMed Central  CAS  PubMed  Google Scholar 

  30. Murray J, Sonnenberg P, Shearer SC, Godfrey-Faussett P. Human immunodeficiency virus and the outcome of treatment for new and recurrent pulmonary tuberculosis in African patients. Am J Respir Crit Care Med. 1999;159:733–40.

    Article  CAS  PubMed  Google Scholar 

  31. Caminero JA, Pena MJ, Campos-Herrero MI, Rodríguez JC, Afonso O, Martin C, et al. Exogenous reinfection with tuberculosis on a European island with a moderate incidence of disease. Am J Respir Crit Care Med. 2001;163:717–20.

    Article  CAS  PubMed  Google Scholar 

  32. Martín A, Herranz M, Navarro Y, Lasarte S, Ruiz Serrano MJ, Bouza E, et al. Evaluation of the inaccurate assignment of mixed infections by Mycobacterium tuberculosis as exogenous reinfection and analysis of the potential role of bacterial factors in reinfection. J Clin Microbiol. 2011;49:1331–8.

    Article  PubMed Central  PubMed  Google Scholar 

  33. Houben RM, Crampin AC, Ndhlovu R, Sonnenberg P, Godfrey-Faussett P, Haas WH, et al. Human immunodeficiency virus associated tuberculosis more often due to recent infection than reactivation of latent infection. Int J Tuberc Lung Dis. 2011;15:24–31.

    Article  CAS  PubMed  Google Scholar 

  34. Glynn JR, Murray J, Bester A, Nelson G, Shearer S, Sonnenberg P. High rates of recurrence in HIV-infected and HIV-uninfected patients with tuberculosis. J Infect Dis. 2010;201:704–11.

    Article  PubMed  Google Scholar 

  35. Laserson KF, Thorpe LE, Leimane V, Weyer K, Mitnick CD, Riekstina V, Zarovska E, Rich ML, Fraser HS, Alarcón E, Cegielski JP, Grzemska M, Gupta R, Espinal M. Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2005;9:640–5.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We owe a debt to Anna Pavan, formerly responsible for the Unit for Prevention, Hygiene and Infectious Diseases of the Health’s General Office, Lombardy region for access to TB regional database. All authors have seen and approved the manuscript and contributed significantly to the work. The manuscript has not been previously published or considered for publication elsewhere.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Consuelo Schiroli.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schiroli, C., Carugati, M., Zanini, F. et al. Exogenous reinfection of tuberculosis in a low-burden area. Infection 43, 647–653 (2015). https://doi.org/10.1007/s15010-015-0759-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15010-015-0759-9

Keywords

Navigation